Role of alterations in ca2+‐associated signaling pathways in the immunotoxicity of polycyclic aromatic hydrocarbons
- 1 June 1995
- journal article
- review article
- Published by Taylor & Francis in Journal of Toxicology and Environmental Health
- Vol. 45 (2) , 101-126
- https://doi.org/10.1080/15287399509531985
Abstract
Polycylic aromatic hydrocarbons (PAHs) are an important class of environmental pollutants that are known to be carcinogenic and immunotoxic. The effects of PAHs on the immune system of various animals and models have been studied for at least 30 yr. Despite these efforts, the mechanism or mechanisms by which PAHs exert their effects on the immune system are still largely unknown. During recent years, the molecular events associated with lymphocyte activation and receptor‐mediated signaling have become increasingly clear. Substantial progress has been made in understanding the molecular and cellular bases for toxicant‐induced immune cell injury. Understanding mechanisms of drug or chemical effects on the immune system is an important area of research in the field of immunotoxicology, and indeed in all fields of toxicology. Mechanistic toxicology plays an important role in risk assessment and extrapolation of potential human health effects. In this review, we have summarized recent evidence that has examined the effects of PAHs on the immune system of animals and humans. In particular, we have focused on the effects of PAHs on cell signaling in lymphoid cells and have examined the hypothesis that PAHs alter lymphocyte activation via calcium‐dependent mechanisms. Previously published reports are discussed, and new data obtained with murine B cells and cell lines are presented demonstrating the relationship between alterations in intracellular calcium and immune dysregulation. These data demonstrate a strong association between PAH‐induced alterations in B‐ and T‐lymphocyte activation and changes in calcium homeostasis.Keywords
This publication has 85 references indexed in Scilit:
- Signal transduction by lymphocyte antigen receptorsCell, 1994
- Inhibition of calcium-dependent pathways of B-cell activation by DMBAToxicology and Applied Pharmacology, 1992
- Suppression of murine cytotoxic T-lymphocyte induction following exposure to 7,12-dimethylbenz[a]anthracene: Dysfunction of antigen recognitionInternational Journal of Immunopharmacology, 1989
- Functional and biochemical disposition of 7,12-dimethylbenz[a]anthracene in murine lymphoid cellsChemico-Biological Interactions, 1989
- Inhibition of IL-2 responsiveness following exposure to benzo(A)pyrene is due to alterations in accessory cell functionInternational Journal of Immunopharmacology, 1988
- Persistent suppression of humoral immunity produced by 7,12-dimethylbenz(a)anthracene (DMBA) in B6C3F1 mice: Correlation with changes in spleen cell surface markers detected by flow cytometryInternational Journal of Immunopharmacology, 1988
- Neutrophil-derived oxidants as mediators of chemical activation in bone marrowChemico-Biological Interactions, 1988
- Suppression of T-helper cell function in mice following exposure to the carcinogen 7,12-dimethylbenz[a]anthracene and its restoration by interleukin-2International Journal of Immunopharmacology, 1987
- Immunosuppression following 7,12-dimethylbenz[a]anthracene exposure in B6C3F1 mice—II. Altered cell-mediated immunity and tumor resistanceInternational Journal of Immunopharmacology, 1986
- An overview of immunotoxicology and carcinogenic polycyclic aromatic hydrocarbonsEnvironmental Carcinogenesis Reviews, 1986